Genetically encoded biosensors are powerful tools for
product-driven
high-throughput screening in synthetic biology and metabolic engineering.
However, most biosensors can only properly function in a limited concentration
cutoff, and the incompatible performance characteristics of biosensors
will lead to false positives or failure in screening. The transcription
factor (TF)-based biosensors are usually organized in modular architecture
and function in a regulator-depended manner, whose performance properties
can be fine-tuned by modifying the expression level of the TF. In
this study, we modulated the performance characteristics, including
sensitivity and operating range, of an MphR-based erythromycin biosensor
by fine-adjusting regulator expression levels via ribosome-binding
site (RBS) engineering and obtained a panel of biosensors with varied
sensitivities by iterative fluorescence-assisted cell sorting (FACS)
in Escherichia coli to accommodate
different screening purposes. To exemplify their application potential,
two engineered biosensors with 10-fold different sensitivities were
employed in the precise high-throughput screening by microfluidic-based
fluorescence-activated droplet sorting (FADS) of Saccharopolyspora
erythraea mutant libraries with different starting
erythromycin productions, and mutants representing as high as 6.8
folds and over 100% of production improvements were obtained starting
from the wild-type strain and the high-producing industrial strain,
respectively. This work demonstrated a simple strategy to engineer
biosensor performance properties, which was significant to stepwise
strain engineering and production improvement.